AIATELLA

Vision ➨ Reality in just 2 years This year at SLUSH, we experienced the profound impact our technology can have on real people, with real stories. This has always been our mission, and now we see it coming to fruition. SLUSH has always been a fantastic platform for connecting the ecosystem, sharing knowledge, and collaboration. However, this year meant so much more for us. Through a technical demonstration of carotid artery screening, we showed how our technology can detect cardiovascular issues that might otherwise go unnoticed, validating just how important this work is. The tangible impact of our work was highlighted during our CEO Jack's presentation on the Startup Stage. He emphasised our broader mission: to automate cardiovascular analysis and exponentiate productivity, ultimately expanding access to preventative screening. This approach enables us to identify diseases long before they become critical. On behalf of the whole team, we'd like to extend our deepest gratitude to: • Tiina Ketonen and Pihlajalinna for expert clinical oversight  • The whole team at Maria 01 for hosting us, and Sarita Runeberg for spreading the word! • The Nordic Science Investments team for their insights and support so far. We're already impacting lives! • Slush for providing an exceptional platform for innovation, special mention to Maryama Moalim • Every participant who took part in the demonstration - you have helped advance the future of AI-powered prevention If you're concerned about your cardiovascular risk or want to learn more about our technology, please reach out.

🚀 We love Y Science! 🚀 Our partner Alexandra Gylfe PhD delivered an inspiring talk at Slush Y Science on "Research Commercialization Through VC Collaboration" to a packed house of 1,000+ attendees. Here are the highlights: 1️⃣ A Strong Foundation for Spinouts: University spinouts in Finland make up 20% of the top ten recent biggest exits. In general, only 10% of university spinouts fail within their first five years, proving they are far less risky than generally presumed. 2️⃣ Bridging Worlds: As a former researcher and biotech executive, Alexandra shared her journey from cancer research to venture capital, highlighting the critical need for stronger collaboration between VCs and university researchers to unlock the full potential of commercialization projects. 3️⃣ AI in Action: AI is reshaping life sciences and deep tech by dramatically accelerating innovation, driving breakthroughs in areas like disease detection, diagnosis, and complex data analysis. Alexandra highlighted AIATELLA, an NSI portfolio company, which conducted AI-powered vascular screenings for hundreds of Slush participants at their booth, providing instant insights into cardiovascular health. 💫 A big thank you to Orion Corporation, University of Helsinki and Helsinki Innovation Services Ltd for the invitation and for organizing such an inspiring event! #SlushYScience #NordicResearch #DeepTech #Spinout

Wrapping up a fantastic demo day at Maria 01 We discussed our work in cardiovascular diagnostics, automating the most time-consuming and subjective tasks in scan analysis. We talked about international collaboration and how patient involvement in healthcare innovation is an absolute must. The real showstopper however was our live demonstration of how our AI can be applied to the early detection and prevention of these diseases. Thank you to all who took part. You’re building the future with us! See you at #SLUSH tomorrow! Special thanks to Robert Evans for featuring in this demo with an audience 😅

Today, we're proud to announce the new cohort for #AcceleratingFemTech, our innovator support programme funded by Innovate UK in collaboration with Medical Research Council.   21 of the best early stage early-stage companies, university spinouts and entrepreneurial-minded academics from across the UK have been chosen for their work in driving innovation across a wide range of women’s health challenges.   These innovations have the potential to make a real difference to women's lives, from improving menstrual and reproductive health with advanced diagnostics and wearable technologies to enhancing support for women experiencing menopause.   Meet the new #AcceleratingFemTech cohort: https://lnkd.in/e_HnpQGf

Pihlajalinnan kuvantamisen ylilääkäri Tiina Ketonen on mukana Slush 2024 -tapahtumassa yhteistyössä AIATELLAn kanssa. 👏 AIATELLA kehittää tekoälypohjaisia uraauurtavia ratkaisuja sydän- ja verisuonitauteihin liittyvien CT-, MRI- ja ultraäänikuvien analysointiin. Olemme tärkeän asian äärellä, sillä sydän- ja verissuonisairaudet ovat maailmanlaajuisesti yleisin kuolinsyy.   Tervetuloa tapaamaan Tiinaa ja AIATELLAn taustahenkilöitä Slushiin Maria 01 -alueelle! ➡️🗓️ 20.-21.11.2024 Slush (Maria01 Booth) #Pihlajalinna #pihlajalinnalaiset #Aiatella #Slush

AIATELLA is heading to Slush and, together with Pihlajalinna, we're bringing our cutting-edge cardiovascular tech with us to the Maria 01 booth! We're addressing the world's leading cause of death by transforming cardiovascular diagnostics through faster, more accurate analysis - part of our mission to make preventive care accessible to all. To demonstrate our solution, we're offering FREE carotid ultrasound screenings during Slush. Find us at: 🗓️ November 19th: Maria01 'Blue Room' 🗓️ November 20-21st: Slush (Maria01 Booth) Don't miss this opportunity to prioritise your health and experience firsthand how AI is revolutionizing cardiovascular care!

🏙️FAIR would like to thank the amazing Smart City Expo World Congress for a fantastic event! A special shoutout to Business Helsinki and all the incredible companies that joined us in promoting Finnish entrepreneurship, sustainable construction, and urban innovation in Barcelona. 🙏   💥We were thrilled to see our client companies pitching their solutions and discussing technological advancements alongside top experts on international stages. Jack Parker, CEO and co-founder of AIATELLA, one of FAIR's customers, highlighted AIATELLA's work in automating medical image analysis and emphasized the importance of transparency and clarity during rapid technological progress.   ☝It was also fantastic to see Pictue's CEO Ville Hyvärinen pitch their solution that streamlines storing and organizing massive volumes of images in seconds—whether for construction sites or urban planning. FAIR is proud to support Pictue’s growth, including developing a new Proof of Concept for their technology. 💯   ✔️ Seeing Finnish innovation shine on an international platform is always inspiring. We look forward to pushing boundaries together for a more sustainable future!   #SmartCityExpo #Innovation #FinnishEntrepreneurship #SustainableCities #TechForGood #Startups #DeepTech #AI

We’re a #BIHA2024 finalist! Our work to support Doctors in the #prevention, #diagnosis and management of #cardiovasculardisease has been shortlisted at this year’s Bright Ideas in Health Awards! We’re incredibly proud of the team, and it’s an honour to see this work recognised and in the running for the Innovative MedTech award. Congratulations and good luck to all the finalists! We’re looking forward to seeing everyone at the award show in November. The full list of finalists across the ten categories can be found at: https://lnkd.in/gzch9r8 #BIHA2024 David Ripley Anna Beattie Haytham Hamid Saira Malik North East and North Cumbria NHS Health Innovation North East and North Cumbria

We are thrilled to announce our partnership with Nordic Science Investments! Our shared vision for the future of deep tech is what makes this collaboration so exciting. The NSI team understands the challenges and opportunities in commercialising cutting-edge research; and their expertise is invaluable as we work to bring our technology to market - transforming Cardiovascular diagnostics and saving lives! 🚀

We are incredibly excited to announce that Molly O'Neill has joined AIATELLA as an Advisor! Molly’s wealth of experience in strategy for multiple major health institutions including, Duke Health, Tenet Healthcare, Mass General Brigham and proven track record driving growth in venture and private equity backed MedTech, education and care delivery companies, is particularly noteworthy. Her knowledge of the inner workings of the US healthcare ecosystem fills a critical gap in our team. As we expand to North America, her insights into the unique challenges and opportunities of the within US healthcare will be invaluable. "As we continue to build upon our current cardiovascular AI applications and evidence base for our technology, it's now about delivering it to physician users and benefiting patients. By automating the time-consuming and subjective task of measurements, Radiologists and Cardiologists can focus on tasks that require their level of expertise." It's not just Molly's expertise that excites us, but also her alignment with our mission. Like us, she believes in the power of AI to genuinely improve patient outcomes by augmenting clinical workflows; and understands that we must work side-by-side with physicians on the front line to achieve this - "It's one thing to design and implement strategy at the enterprise level, but working with AIATELLA brings me back delivering solutions to the front line. AIATELLA is providing an actionable, precision medicine tool that Radiologists not only want, but need; while immediately benefitting patient care." A warm welcome to the AIATELLA team Molly!